Antikor receive £500k from Innovate UK for R&D into ovarian cancer treatment Gallery Antikor receive £500k from Innovate UK for R&D into ovarian cancer treatmentsureyya hilmi2024-11-01T10:26:40+00:0001/11/2024|Read More
Cytiva opens its first Innovation Hub in Korea Gallery Cytiva opens its first Innovation Hub in Koreasureyya hilmi2024-10-31T15:59:56+00:0031/10/2024|Read More
Halloween Social with networking, fancy dress and themed cookies Gallery Halloween Social with networking, fancy dress and themed cookiessureyya hilmi2024-11-01T10:47:28+00:0031/10/2024|Read More
Recruitment of Operations Director at SBC Gallery Recruitment of Operations Director at SBCsureyya hilmi2024-10-30T09:50:34+00:0030/10/2024|Read More
David Mudd, Retirement as Operations Director of Stevenage Bioscience Catalyst Gallery David Mudd, Retirement as Operations Director of Stevenage Bioscience Catalystsureyya hilmi2024-10-25T16:27:18+01:0025/10/2024|Read More
APPA Phase 2b Clinical Trial for Osteoarthritis (OA) Treatment Ahead of Schedule Gallery APPA Phase 2b Clinical Trial for Osteoarthritis (OA) Treatment Ahead of Schedulesureyya hilmi2024-11-01T12:45:22+00:0025/10/2024|Read More
Revolo Shares New Preclinical Data Showcasing the Potential of Sublingual ‘1104 in Allergic Disease Gallery Revolo Shares New Preclinical Data Showcasing the Potential of Sublingual ‘1104 in Allergic Diseasesureyya hilmi2024-11-01T10:58:16+00:0021/10/2024|Read More
VasoDynamics meets with regulatory authority to discuss next Steps for mouthwash treatment for Cancer patients Gallery VasoDynamics meets with regulatory authority to discuss next Steps for mouthwash treatment for Cancer patientssureyya hilmi2024-11-01T11:08:11+00:0018/10/2024|Read More
SBC Scoops Most Successful Science Park (Small) Award at UKSPA 40th Anniversary Conference Gallery SBC Scoops Most Successful Science Park (Small) Award at UKSPA 40th Anniversary Conferencesureyya hilmi2024-10-18T15:23:47+01:0018/10/2024|Read More
CGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapies Gallery CGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiessureyya hilmi2024-10-31T15:27:38+00:0015/10/2024|Read More
GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A Gallery GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to Asureyya hilmi2024-10-12T11:41:08+01:0011/10/2024|Read More
GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trial Gallery GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trialsureyya hilmi2024-10-12T11:16:51+01:0011/10/2024|Read More
Catalent and the Cell and Gene Therapy Catapult to produce two training courses to upskill the advanced therapy sector workforce Gallery Catalent and the Cell and Gene Therapy Catapult to produce two training courses to upskill the advanced therapy sector workforcesureyya hilmi2024-10-12T11:55:54+01:0010/10/2024|Read More
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries Gallery ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countriessureyya hilmi2024-10-12T11:17:05+01:0007/10/2024|Read More
13 Teams Join SBC’s Charity Badminton Tournament Gallery 13 Teams Join SBC’s Charity Badminton Tournamentsureyya hilmi2024-10-12T11:26:44+01:0002/10/2024|Read More
Welcome Cambridge Medixine to the Lab Hotel Gallery Welcome Cambridge Medixine to the Lab Hotelsureyya hilmi2024-10-12T10:56:58+01:0001/10/2024|Read More
Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Gallery Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancerssureyya hilmi2024-10-12T11:24:40+01:0030/09/2024|Read More
Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseases Gallery Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseasessureyya hilmi2024-10-12T11:36:05+01:0026/09/2024|Read More
Setting new benchmarks in cancer treatment research, Cytiva’s Via Extractor tissue disaggregator is being used to create dissociated tumour cell suspensions with high viability and yield. Gallery Setting new benchmarks in cancer treatment research, Cytiva’s Via Extractor tissue disaggregator is being used to create dissociated tumour cell suspensions with high viability and yield.sureyya hilmi2024-10-12T13:34:20+01:0025/09/2024|Read More
Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104 Gallery Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104sureyya hilmi2024-09-19T09:53:52+01:0018/09/2024|Read More